ITGR
Integer Holdings Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -17.6% ·
share flow +4.1% ·
net new positions -20.0%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 2.21K | $279,897 | n/a | −2 |
| Q2 2026 | 101 | +2 | 28.79M | $2.68B | +9 | −9 |
| Q1 2026 | 104 | -9 | 26.92M | $2.35B | +3 | −12 |
| Q4 2025 | 112 | 0 | 26.76M | $2.10B | +2 | −2 |
| Q3 2025 | 18 | +1 | 15.88M | $1.64B | +2 | −1 |
| Q2 2025 | 14 | -3 | 14.18M | $1.74B | n/a | −3 |
| Q1 2025 | 14 | +3 | 3.90M | $459.91M | +4 | −1 |
| Q4 2024 | 11 | 0 | 3.37M | $446.77M | n/a | n/a |
| Q3 2024 | 10 | 0 | 2.03M | $264.18M | n/a | n/a |
| Q2 2024 | 10 | n/a | 2.05M | $237.56M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 5.20M | n/a | $638.97M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (passive) | 3.91M | n/a | $480.79M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 1.33M | +1.0% | $163.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Viking Global Investors ✦ | 1.28M | +9.1% | $157.89M | 0.5% | ▲ Add | 5 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 819.09K | +3.9% | $100.74M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 613.57K | n/a | $75.45M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 7 | Citadel Advisors ✦ | 434.44K | +1606.4% | $53.42M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 257.31K | +109.0% | $31.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 217.43K | +209.2% | $26.74M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 66.72K | +4.9% | $8.20M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 27.69K | +11.8% | $3.40M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | GAMCO Investors ✦ | 18.88K | -0.3% | $2.32M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 4.70K | +52.7% | $577,837 | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 14 | Gotham Asset Management ✦ | 2.09K | -13.9% | $257,007 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Point72 Asset Management | $23.55M | was 0.1% |
| Soros Fund Management | $7.29M | was 0.2% |
| Marshall Wace | $3.08M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 3 holders, 175.00K shares, $206,675 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 11.77K sh · $1.49M
Officer · 19.77K sh · $2.50M
Officer · 9.41K sh · $1.19M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
14.0% of class · View original SEC filing ↗